Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rudick

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Biologic effects of interferons: relevance to multiple sclerosisR A Rudick, R M Ransohoff
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Interferon-beta treatment for multiple sclerosisRobert A Bermel, Richard A Rudick
CNS Drugs|September 16, 2008
Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatmentRichard A Rudick, Deborah M Miller
Neurology|April 28, 2010
The multiple sclerosis functional composite: a clinically meaningful measure of disabilityChris H Polman, Richard A Rudick
Experimental Cell Research|March 15, 2011
Beta-interferon for multiple sclerosisRichard A Rudick, Susan E Goelz
Neurobiology of Aging|January 1, 1983
Integrity of blood-brain barrier to peroxidase in senescent miceR A Rudick, S J Buell
Archives of Neurology|March 1, 1992
Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activityR A Rudick, R M Ransohoff
CNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A Rudick
Science Translational Medicine|April 7, 2010
A radical proposal: integrate clinical investigation into the U.S. health care systemRichard A Rudick, Delos M Cosgrove
The Lancet. Neurology|May 19, 2009
Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosisRichard A Rudick, Chris H Polman
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Biologic effects of interferons: relevance to multiple sclerosisR A Rudick, R M Ransohoff
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Interferon-beta treatment for multiple sclerosisRobert A Bermel, Richard A Rudick
CNS Drugs|September 16, 2008
Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatmentRichard A Rudick, Deborah M Miller
Neurology|April 28, 2010
The multiple sclerosis functional composite: a clinically meaningful measure of disabilityChris H Polman, Richard A Rudick
Experimental Cell Research|March 15, 2011
Beta-interferon for multiple sclerosisRichard A Rudick, Susan E Goelz
Neurobiology of Aging|January 1, 1983
Integrity of blood-brain barrier to peroxidase in senescent miceR A Rudick, S J Buell
Archives of Neurology|March 1, 1992
Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activityR A Rudick, R M Ransohoff
CNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A Rudick
Science Translational Medicine|April 7, 2010
A radical proposal: integrate clinical investigation into the U.S. health care systemRichard A Rudick, Delos M Cosgrove
The Lancet. Neurology|May 19, 2009
Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosisRichard A Rudick, Chris H Polman
Pageof 19